The blockbuster cancer drug Keytruda can cost over $150,000 | The Excerpt

Last December, President Donald Trump convened a meeting of pharmaceutical executives with the goal of getting them to lower the cost of prescription drugs. A few weeks later, one patient battling lung cancer checked into a California clinic for an infusion of Merck & Co.'s blockbuster cancer drug, Keytruda. When the bill arrived, the clinic's charge for a 400 mg dose dominated the page: It was just over $162,000. While Brown only owed about $2,000 herself, the six-figure charges show how quickly prices for cutting-edge medical treatments can balloon in the U.S. health care system. USA TODAY joined the International Consortium of Investigative Journalists in their year-long, reporting effort looking into rising healthcare costs around the world. USA TODAY Health Reporter Ken Alltucker joined The Excerpt to share his insights.

Read more: https://tinyurl.com/38exmk5v
Sign up for our newsletter for the day's top stories, from sports to movies to politics to world events: https://profile.usatoday.com/newsletters/daily-briefing/

Видео The blockbuster cancer drug Keytruda can cost over $150,000 | The Excerpt канала USA TODAY